Edgewise Therapeutics, Inc.
Long
Updated

$EWTX is giving a GREAT IPO LONG opportunity today

286
IPO intraday trading strategy idea

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders.

The share price is rising and gonna continue this trend today.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price today.

So I opened a long position from $27,58;
stop-loss — $25,11;
take-profit — 34,99/MOC price.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.
Trade closed: stop reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.